Drugmakers, Pharmacies Next Targets for U.S. Opioid Settlements
“With a $26 billion nationwide settlement in sight over claims that the three largest U.S. drug distributors and Johnson & Johnson (JNJ.N) helped fuel a nationwide opioid epidemic, state and local governments will soon turn their attention to pharmacies and a handful of drugmakers,” reports Brendan Pierson in Reuters.
“U.S. state attorneys general are expected to unveil a settlement proposal this week with distributors McKesson Corp (MCK.N), Cardinal Health Inc (CAH.N) and AmerisourceBergen Corp (ABC.N) contributing a combined $21 billion, while Johnson & Johnson would pay $5 billion.”
